April 16 — According to the 2025 annual report released by Yuntu Holdings on the evening of April 14, the company achieved operating revenue of 21.4 billion yuan in 2025, a year-on-year increase of 5.01%; net profit attributable to shareholders of the listed company reached 827 million yuan, up 2.81% year-on-year; non-GAAP net profit was 803 million yuan, an increase of 11.99% year-on-year; and net cash flow from operating activities amounted to 1.257 billion yuan, surging 99.36% year-on-year.

Chempricehub Analysis on Phosphoric Acid, Bull-Bear Score: 1.5
Yuntu Holdings’ 2025 performance report indicates a 5.01% year-on-year growth in revenue, a 2.81% increase in net profit, and an 11.99% rise in non-GAAP net profit. Notably, net cash flow from operating activities surged by 99.36% year-on-year, reflecting ample capital and improved operational efficiency. As a phosphoric acid producer, the steady performance may suggest stronger industry demand or production expansion, thereby boosting spot market demand for phosphoric acid and supporting an upward price trend.

Monoammonium Phosphate (MAP), Bull-Bear Score: 1.5
Based on Yuntu Holdings’ 2025 performance report, the company achieved growth in revenue, net profit, and cash flow, with net cash flow soaring 99.36% year-on-year, indicating financial health and production potential. As one of the company’s core products, the positive performance of monoammonium phosphate may imply increased downstream fertilizer demand or optimized supply, exerting a positive pull on spot prices and benefiting market supply-demand balance.